$FISV, $FULC, $GMAB, $HUM, $NEWR, $NWSA, $OKE, $SYMC, $UBER
Below is a list of stocks analysts have singled out to look at carefully Tuesday, as follows:
Fiserv Inc. (NASDAQ:FISV) was reiterated as Buy and the target price was raised to 120 at Argus.
Fulcrum Therapeutics Inc. (NASDAQ:FULC) was started with a Buy rating and assigned a 19 price objective at Merrill Lynch.
Genmab A/S (NASDAQ:GMAB) was up 0.7% at $18.94 Friday and was indicated up almost 2% more at $19.30 Monday. RBC Capital Markets started it as Outperform, Guggenheim started it as Buy and Morgan Stanley started it as Overweight.
Humana Inc. (NYSE:HUM) was raised to Overweight from Neutral and the target price was raised to 345 from 300 at Cantor Fitz.
New Relic Inc. (NYSE:NEWR) was raised to Buy from Hold with 93 target price at Argus.
News Corp. (NASDAQ:NWSA) was raised to Outperform from Neutral at Credit Suisse, noting a focus on value after earnings.
ONEOK Inc. (NYSE:OKE) was raised to Buy from Neutral and the target price was raised to 75 from 69 at UBS.
Symantec Corp. (NASDAQ:SYMC) was reiterated as Hold at Argus following its enterprise sale to Broadcom.
Uber Technologies Inc. (NYSE:UBER) was reiterated as Outperform and the target price was raised to 56.00 from 54 at JMP Securities. Uber Vs Lyft earnings and analyst scorecard was not what the post-earnings initial headlines and reactions might have indicated.